TWYNSTA
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TWYNSTA in Canada?
A shortage of TWYNSTA 80MG 5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 21, 2026), but it has not started yet.
Why is TWYNSTA not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TWYNSTA be available again?
The manufacturer's estimated resolution date is December 14, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-12-14
~3 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02371049
Strength
80MG 5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
TELMISARTAN AMLODIPINE
Tier
Unrated
Last Updated
2026-09-21
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02242119
250MG · DIN 02273322
20MCG · DIN 02247686
DIN 02419106
DIN 02231675
0.4MG · DIN 02270102
40MG · DIN 02415682
20MG · DIN 02415666
30MG · DIN 02415674
DIN 02459760
DIN 02459752
DIN 02441888